Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    StockNews24StockNews24
    Subscribe
    • Shares
    • News
      • Featured Company
      • News Overview
        • Company news
        • Expert Columns
        • Germany
        • USA
        • Price movements
        • Default values
        • Small caps
        • Business
      • News Search
        • Stock News
        • CFD News
        • Foreign exchange news
        • ETF News
        • Money, Career & Lifestyle News
      • Index News
        • DAX News
        • MDAX News
        • TecDAX News
        • Dow Jones News
        • Eurostoxx News
        • NASDAQ News
        • ATX News
        • S&P 500 News
      • Other Topics
        • Private Finance News
        • Commodity News
        • Certificate News
        • Interest rate news
        • SMI News
        • Nikkei 225 News1
    • Carbon Markets
    • Raw materials
    • Funds
    • Bonds
    • Currency
    • Crypto
    • English
      • العربية
      • 简体中文
      • Nederlands
      • English
      • Français
      • Deutsch
      • Italiano
      • Português
      • Русский
      • Español
    StockNews24StockNews24
    Home » Walgreens turnaround strategy, sale of VillageMD boosts 2025 Q1
    Cryptocurrency News

    Walgreens turnaround strategy, sale of VillageMD boosts 2025 Q1

    userBy userJanuary 11, 2025No Comments3 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Walgreens Boots Alliance (WBA) beat Wall Street estimates on its adjusted earnings per share and sales for the first quarter of fiscal year 2025 on Friday, even as questions remain about its future as a public company.

    The company reported $39.5 billion in revenue for the quarter, up 7% from the same quarter last quarter and above Bloomberg consensus estimates of $37.3 billion. Walgreens also reported adjusted earnings per share of $0.51, compared to consensus estimates of $0.38 per share.

    The company saw lower-than-expected sales of vaccines and over-the-counter flu season medicine, as the winter respiratory virus season has not been as bad as in previous years.

    The stock traded higher Friday, up 27% to $11.70 per share, on the news the company is moving ahead with its separation of the VillageMD healthcare services business. Walgreens has pursued a shift in strategy since CEO Tim Wentworth took over in late 2023.

    NasdaqGS – Delayed Quote • USD

    At close: January 10 at 4:00:01 PM EST

    VillageMD has been performing poorly, resulting in an operating loss for Walgreens’ books. This quarter it performed slightly better, along with the company’s pharmacy benefits manager, Shields. Together, they reported a loss of $325 million, compared to a $436 million loss in the prior period.

    The company is still evaluating what to do with New Jersey-based Summit Health and CityMD urgent care centers, which were also part of the VillageMD controlling stake acquisition in 2021.

    In this June 4, 2014, file photo, people walk in to a Walgreens retail store in Boston. (AP Photo/Charles Krupa, File) · ASSOCIATED PRESS

    The company has faced a number of pressures, which spurred a round of store closures amid a tough retail environment. Front-of-store sales have typically been a drag on all retail pharmacies in recent years as customers pivot to shopping online and through other avenues.

    Wentworth highlighted some improvements in the store experience, including a digital waiting list for prescription pick-up to help customers avoid taking up pharmacists’ time while they are trying to get prescriptions filled.

    Wentworth said this would allow customers a chance to shop while they wait. If they do, the customers will face groupings of products; for example, some might focus on women’s health. It’s a way of meeting customers’ needs where they are, he said.

    Walgreens is still in the process of closing about 450 low-performing stores, 67 of which were closed as of the first quarter.

    “This turnaround — we’ve said it’s going to take time … and we are committed to our vision of a retail pharmacy-led organization,” Wentworth said during an earnings call Friday, noting that there is a “level of urgency, discipline, and focus” throughout the organization.



    Source link

    Share this:

    • Click to share on Facebook (Opens in new window) Facebook
    • Click to share on X (Opens in new window) X

    Like this:

    Like Loading...

    Related

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleWells Fargo’s top five portfolio ideas for 2025 By Investing.com
    Next Article Could Investing $1,000 in Apple Make You a Millionaire?
    user
    • Website

    Related Posts

    What Does It Mean to Be Risk Neutral as an Investor?

    January 18, 2025

    SLB boosts dividend and buybacks, but warns of oil oversupply

    January 17, 2025

    Intel Stock Soars as Takeover Speculation Spreads

    January 17, 2025
    Add A Comment

    Leave a ReplyCancel reply

    © 2025 StockNews24. Designed by Sujon.

    Type above and press Enter to search. Press Esc to cancel.

    %d